Viewing Study NCT04304820


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-01-15 @ 3:38 PM
Study NCT ID: NCT04304820
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2020-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Aplastic Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunosuppression View
None T-cells View
None Hematopoiesis View
None Autoimmunity View
None Thrombocytopenia View